Lori L. Sinclair

Celecoxib Toxicity Is Cell Cycle Phase Specific

Jonathan M. Bock, Sarita G. Menon, Lori L. Sinclair et al. · Cancer Research · 2007 · 40 citations · Full text

Retrospective analysis of the diagnostic yield of newborn drug testing

Kelly E. Wood, Lori L. Sinclair, Carolyn D Rysgaard et al. · BMC Pregnancy and Childbirth · 2014 · 33 citations · Full text

Modulation of Cellular Invasion by VEGF-C Expression in Squamous Cell Carcinoma of the Head and Neck

Jonathan M. Bock, Lori L. Sinclair, Nichole S. Bedford et al. · Archives of Otolaryngology - Head and Neck Surgery · 2008 · 23 citations

Relative non‐steroidal anti‐inflammatory drug (NSAID) antiproliferative activity is mediated through p21‐induced G1 arrest and E2F inhibition

Jonathan M. Bock, Sarita G. Menon, Prabhat C. Goswami et al. · Molecular Carcinogenesis · 2007 · 22 citations

Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition

Jonathan M. Bock, Sarita G. Menon, Prabhat C. Goswami et al. · Cancer Biology & Therapy · 2007 · 10 citations · Full text